Show simple item record

Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer

dc.contributor.authorLustberg, M.
dc.contributor.authorWu, X.
dc.contributor.authorFernández Martínez, Juan Luis 
dc.contributor.authorAndrés Galiana, Enrique Juan de 
dc.contributor.authorPhilips, S.
dc.contributor.authorLeibowitz, J.
dc.contributor.authorSchneider, B.
dc.contributor.authorSonis, S.
dc.date.accessioned2023-08-28T09:41:52Z
dc.date.available2023-08-28T09:41:52Z
dc.date.issued2023
dc.identifier.citationSupportive Care in Cancer, 31(3), (2023); doi:10.1007/s00520-023-07617-6
dc.identifier.issn0941-4355
dc.identifier.urihttps://hdl.handle.net/10651/69398
dc.description.sponsorshipThis work was supported by grants from Division of Cancer Prevention, National Cancer Institute (R01CA238946-02).
dc.language.isoeng
dc.relation.ispartofSupportive Care in Cancer
dc.rights© 2023, The author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85148678327&doi=10.1007%2fs00520-023-07617-6&partnerID=40&md5=18617c73ab662c8c7b65cf388f049ada
dc.titleLeveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer
dc.typejournal article
dc.identifier.doi10.1007/s00520-023-07617-6
dc.relation.publisherversionhttp://dx.doi.org/10.1007/s00520-023-07617-6


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record